Blog

The development of antibody-based therapeutics has expanded beyond traditional full-length antibodies, with antibody fragments gaining attention for their smaller molecular size, specialized binding properties, and

The development of plasmid DNA-based products requires more than simply producing sufficient quantities of genetic material. As gene therapies, DNA vaccines, and other advanced biological